Back to search
FDAFDA · Food and drugs·Recall number D-0258-2024

Vasopressin 2 Unit/2 mL in 0.9% Sodium Chloride, 2 mL per syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-0190-1

Published January 31, 2024 · Recall initiated: January 12, 2024

Summary

FDA records drug Class II recall D-0258-2024, published January 31, 2024 and initiated January 12, 2024. Recalling firm: IntegraDose Compounding Services LLC; Status: Ongoing; Reported quantity: 281 syringes; Lot: Lot #: 20230921VAS-2, Exp. Date 03/19/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
IntegraDose Compounding Services LLC
Distributor
MN only
Lot
Lot #: 20230921VAS-2, Exp. Date 03/19/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Vasopressin 2 Unit/2 mL in 0.9% Sodium Chloride, 2 mL per syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-0190-1 recalled?

Yes. FDA published recall D-0258-2024 on January 31, 2024. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter